Trial intelligence / Profile preview

Sarcosine Monotherapy in Acute Schizophrenia

NCT00328276Phase 2Completed

Sponsor
China Medical University Hospital
Start
Dec 2004
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of sarcosine in schizophrenia, sponsored by China Medical University Hospital. Started Dec 2004; status: completed.

02

Drugs

sarcosine
03

Conditions

schizophrenia

Beyond the preview

Go deeper on NCT00328276.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00328276.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call